Bahl & Gaynor Inc Johnson & Johnson Transaction History

Bahl & Gaynor Inc

$17.9 Billion
Q1 2024

A detailed history of Bahl & Gaynor Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Bahl & Gaynor Inc holds 357,988 shares of JNJ stock, worth $52.3 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

357,988

Previous 366,069 2.21%

Holding current value

$52.3 Million

Previous $57.4 Million 1.3%

% of portfolio

0.32%

Previous 0.35%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$155.22 - $162.74 $1.25 Million - $1.32 Million	-8,081 Reduced 2.21%	357,988 $56.6 Million
Q4 2023 Feb 02, 2024	SELL	$145.6 - $158.88 $548,766 - $598,818	-3,769 Reduced 1.02%	366,069 $57.4 Million
Q3 2023 Nov 03, 2023	SELL	$155.75 - $174.48 $6.68 Million - $7.49 Million	-42,916 Reduced 10.4%	369,838 $57.6 Million
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $975,646 - $1.05 Million	-6,321 Reduced 1.51%	412,754 $68.3 Million
Q1 2023 May 03, 2023	SELL	$151.05 - $180.26 $1.59 Million - $1.89 Million	-10,494 Reduced 2.44%	419,075 $65 Million

Q4 2022 Feb 10, 2023	SELL	$160.2 - $179.79 $116,625 - $130,887	-728 Reduced 0.17%	429,569 $75.9 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $83,246 - $92,632	516 Added 0.12%	430,297 $70.3 Million
Q2 2022 Aug 08, 2022	SELL	$168.19 - $186.01 $749,286 - $828,674	-4,455 Reduced 1.03%	429,781 $76.3 Million
Q1 2022 May 12, 2022	SELL	$158.14 - $179.59 $3.18 Million - $3.61 Million	-20,107 Reduced 4.43%	434,236 $77 Million
Q4 2021 Feb 10, 2022	SELL	$155.93 - $173.01 $16.1 Million - $17.8 Million	-103,067 Reduced 18.49%	454,343 $77.7 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $8.08 Million - $8.98 Million	-50,013 Reduced 8.23%	557,410 $90 Million
Q2 2021 Aug 06, 2021	SELL	$159.48 - $171.07 $14.3 Million - $15.3 Million	-89,545 Reduced 12.85%	607,423 $100 Million
Q1 2021 May 11, 2021	SELL	$153.07 - $170.48 $42 Million - $46.8 Million	-274,565 Reduced 28.26%	696,968 $115 Million
Q4 2020 Feb 02, 2021	SELL	$137.11 - $157.38 $78.6 Million - $90.2 Million	-572,963 Reduced 37.1%	971,533 $153 Million
Q3 2020 Nov 12, 2020	SELL	$140.38 - $153.83 $83.5 Million - $91.5 Million	-594,672 Reduced 27.8%	1,544,496 $230 Million
Q2 2020 Aug 13, 2020	BUY	$128.81 - $155.51 $5.07 Million - $6.12 Million	39,366 Added 1.87%	2,139,168 $301 Million
Q1 2020 May 26, 2020	BUY	$111.14 - $153.99 $165 Million - $228 Million	1,480,253 Added 238.92%	2,099,802 $275 Million
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $162 Million - $224 Million	-1,453,972 Reduced 70.12%	619,549 $81.2 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $282,922 - $324,950	-2,219 Reduced 0.11%	2,073,521 $302 Million
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $4.72 Million - $5.28 Million	37,180 Added 1.82%	2,075,740 $269 Million
Q2 2019 Aug 12, 2019	BUY	$131.15 - $144.24 $4.76 Million - $5.24 Million	36,326 Added 1.81%	2,038,560 $284 Million
Q1 2019 May 13, 2019	BUY	$125.72 - $139.79 $3 Million - $3.34 Million	23,861 Added 1.21%	2,002,234 $280 Million
Q4 2018 Feb 12, 2019	BUY	$122.84 - $147.84 $60.7 Million - $73.1 Million	494,453 Added 33.32%	1,978,373 $255 Million
Q3 2018 Nov 09, 2018	SELL	$121.58 - $142.88 $56.1 Million - $65.9 Million	-461,472 Reduced 23.72%	1,483,920 $205 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $11.2 Million - $12.3 Million	93,476 Added 5.05%	1,945,392 $236 Million
Q1 2018 May 11, 2018	SELL	$125.1 - $148.14 $16 Million - $19 Million	-128,278 Reduced 6.48%	1,851,916 $237 Million
Q4 2017 Feb 13, 2018	SELL	$131.22 - $143.62 $3.03 Million - $3.32 Million	-23,090 Reduced 1.15%	1,980,194 $277 Million
Q3 2017 Nov 13, 2017	SELL	$129.47 - $135.38 $576,659 - $602,982	-4,454 Reduced 0.22%	2,003,284 $260 Million
Q2 2017 Aug 11, 2017	SELL	N/A	-18,609 Reduced 0.92%	2,007,738 $266 Million
Q2 2017 Aug 10, 2017	BUY	N/A	2,026,347	2,026,347 $233 Million

Others Institutions Holding JNJ

# of Institutions

4,146

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $382B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.

Account